概述

  • 产品名称Anti-Urokinase抗体
    参阅全部 Urokinase 一抗
  • 描述
    兔多克隆抗体to Urokinase
  • 特异性Recognizes high molecular weight and low molecular weight Urokinase.
  • 经测试应用适用于: ELISA, WBmore details
  • 种属反应性
    与反应: Mouse
  • 免疫原

    Recombinant full length protein (Mouse).

性能

应用

Our Abpromise guarantee covers the use of ab20789 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
ELISA
WB
  • 应用说明ELISA: 1/10000. WB: 1/5000. Predicted molecular weight: 48 kDa. Dilution optimised using Chromogenic detection. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
  • 靶标

    • 功能Specifically cleave the zymogen plasminogen to form the active enzyme plasmin.
    • 组织特异性Expressed in the prostate gland and prostate cancers.
    • 序列相似性Belongs to the peptidase S1 family.
      Contains 1 EGF-like domain.
      Contains 1 kringle domain.
      Contains 1 peptidase S1 domain.
    • 翻译后修饰Phosphorylation of Ser-158 and Ser-323 abolishes proadhesive ability but does not interfere with receptor binding.
    • 细胞定位Secreted.
    • Information by UniProt
    • 数据库链接
    • 别名
      • ATF antibody
      • ATF uPA antibody
      • BDPLT5 antibody
      • Plasminogen activator antibody
      • Plasminogen activator urinary antibody
      • Plasminogen activator urokinase antibody
      • PLAU antibody
      • QPD antibody
      • u PA antibody
      • U plasminogen activator antibody
      • u-PA antibody
      • U-plasminogen activator antibody
      • uPA antibody
      • URK antibody
      • UROK_HUMAN antibody
      • Urokinase plasminogen activator antibody
      • Urokinase type plasminogen activator antibody
      • Urokinase type plasminogen activator precursor antibody
      • Urokinase-type plasminogen activator chain B antibody
      see all

    Anti-Urokinase antibody (ab20789)参考文献

    This product has been referenced in:
    • Hasegawa Y  et al. Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-ß gene. Mol Ther 18:1778-86 (2010). Read more (PubMed: 20606645) »

    See 1 Publication for this product

    Product Wall

    Thank you for your enquiry. I am sorry to hear that you have been having difficulties with this antibody. The results that you have been obtaining are a little confusing. You are detecting what appears to be cleavage fragments under reducing and non...

    Read More

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"